Muscular dystrophy Flashcards
what is muscular dystrophy
-progressive degeneration of skeletal muscle
(d/t atrophy, necrosis & pseudohypertrophy)
there are different types of muscular dystrophy what is the most common
- Duchenne MD is most common
- 1 in 3500 live births (predominantly in male)
how do you determine what type of muscular dystrophy it is?
- MOT- mode of transmission ex. Autosomal, recessive, sex linked
- Muscles ex. (distal) (muscle groups affected)
- rate of progression (months, years, decades)
- age of onset
what is the etiology of muscular dystrophy
-genetic -monogenic
-recessive, x-linked (sex linked)
x-linked recessive mother is carrier to son
what is pseudohypertrophy in muscular dystrophy
fibrofatty connective tissue replaces muscle fibers (something replaces muscle)
what does recessive mean
2 alleles need to be defective
patho of muscular dystrophy
- gene is on short arm of x chromosome:
- codes for dystrophin (membrane protein)
- attachment of contractile filaments(this is normal function of the protein) - mutation causing altered dystrophin which then causes poor contractile protein attachemnt which then causes fiber necrosis with use of muscle and then there is poor repair & regeneration which causes more necrosis
- calcium influx (ca ions move from outside cell to inside cell) & enzyme release (eg. CK-creatinine kinase-subset for skeletal muscle, serum marker which is an indicator of muscle damage)
what are the manifestations of muscular dystrophy?
- asymptomatic until approx 2-3 (muscles less used, injury occurs when muscles used)
- when muscles damaged presentation is muscle weakness
- progressive muscle weakness (all skeletal muscles affected)
- major problem when respiratory muscles & cardiac muscle affected which may occur even though cardiac muscle is not skeletal muscle
- death from resp & cardiac complications
diagnosing muscular dystrophy
- hx, px (movement)
- biopsy of muscle for fibrofatty connective tissue (confirms diagnosis)
- serum Creatinine Kinase (indicates damage to muscles does not confirm diagnosis)
- genetic testing:
- prenatal approx 12 wks
- carrier status (test mother)
treatment of muscular dystrophy
- supportive & symptomatic
- increase comfort & function (assistance with mobility) (breathing exercises, even though injury is inflicted when muscles used, but when muscles not used cause atrophy, cautiously respiratory therapist does breathing exercise)
- individual will likely die from respiratory & cardiac problems